arrow
T

Teresa Lozano

CIBERONC
H指数:25
被引数:2,170

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reprogramming glutamine metabolism enhances BCMA-CART cell fitness and therapeutic efficacy in multiple myeloma

重编程谷氨酰胺代谢增强了BCMA-CART细胞的适应性和在多发性骨髓瘤中的治疗效能。

Blood
IF23.1
2025-09-220
OAAI
Targeting FOXP3 in glioblastoma: Blockade of tumor intrinsic effects boosts response to chemo-radiotherapy

靶向胶质母细胞瘤中的FOXP3:阻断肿瘤内在效应可增强对放化疗的反应

2025-06-270
PRE
PTEN Loss Confers Resistance to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
2023-06-1312
OA
PTEN loss confers resistance to anti-PD-1 therapy in NSCLC by increasing tumor infiltration of T regulatory cells
2023-04-043
PRE
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

用于预测遗传异质性多发性骨髓瘤的免疫治疗结果和免疫逃避机制的临床前模型

2023-03-1628
OAAI
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
2022-09-3034
OAAI
BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis
2022-09-3010
OAAI
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

靶向纤连蛋白的额外结构域A用于car-t细胞的癌症治疗

2022-08-0220
OAAI
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
2021-03-0339
OAAI
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
2020-06-249
OAAI